These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2959332)

  • 21. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
    Hirano M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N; Radojcic V; Powell J; Luznik L
    Transplantation; 2007 Mar; 83(5):631-40. PubMed ID: 17353785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimaerism in lymph nodes of F1 into irradiated parental recipient chimaeras rejecting skin allografts from the other parent.
    Suman L; Silobrcić V; Kastelan A
    Transplantation; 1978 Jun; 25(6):302-4. PubMed ID: 351887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.
    Weiss L; Slavin S
    Bone Marrow Transplant; 1999 Jun; 23(11):1139-43. PubMed ID: 10382953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Split tolerance in spleen chimeras.
    Sprent J; Hurd M; Schaefer M; Heath W
    J Immunol; 1995 Feb; 154(3):1198-206. PubMed ID: 7822792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
    Ramos A; Merino R; Merino J
    Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of burn injury on the reactivity of spleen cells of mice of different genotypes during regional graft vs host reaction].
    Barsukov AN; Fedorov GN; Semenkov VF
    Biull Eksp Biol Med; 1990 Jun; 109(6):592-4. PubMed ID: 2397303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity in canine marrow graft recipients given cyclophosphamide.
    Abb J; Kolb HJ; Grosse-Wilde H; Reider I; Thierfelder S
    Exp Hematol; 1978 Jan; 6(1):58-66. PubMed ID: 146607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation tolerance to MHC antigens in chicken B cell chimeras: effect of chimerism on the transferability of tolerance.
    Lehtonen L; Vainio O; Veromaa T; Toivanen P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):252-6. PubMed ID: 2523131
    [No Abstract]   [Full Text] [Related]  

  • 38. [Organ transplantation. I. Genetics and immunology].
    Häyry P
    Duodecim; 1977; 93(18):1135-51. PubMed ID: 22430
    [No Abstract]   [Full Text] [Related]  

  • 39. Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparities.
    Jackman SH; Boyse EA; Goldberg EH
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):11041-5. PubMed ID: 1438311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Factors determining prolonged chimerism of lymphoid tissue in mice treated with cyclophosphamide].
    Novikov TK; Kondrat'eva IA; Fontalin LN; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1976 Feb; 81(2):194-7. PubMed ID: 945088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.